JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
GLUE Financials - Monte Rosa Therapeutics Income & Cash Flow | Ledgeburg
GLUE - Monte Rosa Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary GLUE Stock
Financials
Financials GLUE Stock
Loading...
Loading...
Income Statement
Income Statement GLUE Stock
Balance Sheet
Balance Sheet GLUE Stock
Cash Flow Statement
Cash Flow Statement GLUE Stock
Loading...
Loading...
Home
Stocks
Monte Rosa Therapeutics, Inc. (GLUE)
Financials
Financials of GLUE
Loading...
Loading...
Loading...
Loading...
Revenue
$123.672M
Operating Income
$-54.208M
Net Income
$-38.626M
Share Count (Basic)
83.071185M
Operating Cash Flow
$-22.798M
Free Cash Flow
$-27.498M
Cash And Short-Term Equivalents
$129.883M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
50M
100M
FY2023
FY2024
FY2025
Revenue $USD
0
20M
40M
60M
80M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-140M
-120M
-100M
-80M
-60M
-40M
Annual
Quarterly
Margins
Gross
Operating
Net
-100%
-80%
-60%
-40%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-40M
-20M
0
20M
40M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-1500%
-1000%
-500%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26